The Problem
Ukraine’s decade-long selective distribution practices in the pharmaceutical market are currently facing unparalleled antitrust scrutiny. This follows the introduction of controversial…
The Lindenapotheke judgment by the European Court of Justice (ECJ) marks a significant development in the interplay between data protection and unfair competition law. In this data protection case, a…
On 27 June 2024, the EU Court of Justice (“CJEU”) issued its judgments in the Perindopril (Servier) case. The judgments follow a European Commission (“EC”) decision of 9 July 2014, and a series of…
At the end of 2023, the Bulgarian Commission for Protection of Competition (“CPC”) issued a key decision related to an abuse of dominance case in the pharmaceutical sector. The decision, which is…
On 10 October 2022, the European Commission (EC) sent a Statement of Objections to Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals Europe BV (Teva). The EC has provisionally found…
In the last edition of the International Law Talk Podcast, I had the pleasure to interview Jay Modrall on the Illumina/Grail saga. Jay talks us through the whole case with all its interesting aspects…
The European Commission's horizontal guidelines are an invaluable tool for practitioners in antitrust compliance work. The team at Unit A1 in DG COMP have done a great job at further developing the…
With the recent decision given by the 13th Chamber of the Council of State on 24 May 2021,[1] the administrative fine given to the Turkish Pharmacists Association (“TPA”) by the Turkish Competition…
The Netherlands Authority for the Consumer and Markets’ ("ACM") announced focus on drug price developments has finally come to a tangible enforcement result: a fine of almost EUR 20 million imposed…
